Oncotarget

Research Papers:

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer

Louise Rasmussen _, Ib Jarle Christensen, Marielle Herzog, Jake Micallef, Hans Jørgen Nielsen and For the Danish Collaborative Group on Early Detection of Colorectal Cancer

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:10247-10258. https://doi.org/10.18632/oncotarget.21908

Metrics: PDF 989 views  |   HTML 1434 views  |   ?  


Abstract

Louise Rasmussen1, Ib Jarle Christensen1, Marielle Herzog2, Jake Micallef2, Hans Jørgen Nielsen1,3 and For the Danish Collaborative Group on Early Detection of Colorectal Cancer4

1Department of Surgical Gastroenterology 360, Hvidovre Hospital, Hvidovre, Denmark

2Belgian Volition SPRL, Isnes, Belgium

3Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

4Appendix

Correspondence to:

Louise Rasmussen, email: lras2905@gmail.com

Keywords: biomarkers, tumor, colorectal neoplasms, early detection of cancer, histone code

Received: December 10, 2016     Accepted: October 10, 2017     Published: October 20, 2017

ABSTRACT

The aim was to evaluate serum levels of circulating cell-free nucleosomes (ccfn) containing a variety of epigenetic signals including 5-methylcytosine DNA, histone modifications H3K9Me3, H3K9Ac, H3S10PO4, H3K36Me3, H4K20Me3, H4PanAc and pH2AX, nucleosome variant H2AZ and nucleosome adducts with HMGB1 and EZH2 as well as ccfn per se, in addition to develop and evaluate predictor models based on the above mentioned ccfn and including serum levels of carcinoembryonic antigen (CEA), in early detection of colorectal cancer (CRC).

Blood-samples were collected from 4,105 individuals undergoing colonoscopy. Serum levels of ccfn and CEA were determined using enzyme-linked immunosorbent assays platforms. Individual assessment of levels of ccfn showed area under the receiver operating characteristic curve (AUCROC) = 0.525–0.576 in discrimination of individuals with CRC from individuals with non-malignant findings. Predictor models including ccfn containing 5-methylcytosine DNA, CEA, age and gender improved results (AUCROC = 0.736, sensitivity = 0.37 at specificity = 0.90). Further improvement was achieved in discrimination of individuals with CRC from individuals with clean colorectum (AUCROC = 0.840, sensitivity = 0.57 at specificity = 0.90). The levels of ccfn among patients with CRC appeared to be stage-independent. In conclusion, the performance of the developed predictor models is potentially promising in early detection of CRC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 21908